The reports of malignancy in coeliac disease (Gough, Read, and Naish, 1962; Austad et al., 1967; Harris et al., 1967) leave little doubt that there is an increased incidence of such complication in this disorder. Malignant lymphoma of the jejunum has been the most common complication but gastrointestinal cancer, at sites other than the small intestine, has been shown to be almost as common.
Coeliac disease is also a familial condition with approximately 10% of first-degree relatives affected (Macdonald, Dobbins, and Rubin, 1965 ; Stokes, Asquith, and Cooke, 1973a) . The mode of inheritance remains to be established but studies of histocompatibility (HL-A) antigens suggest that these, for example HL-A8, are important factors in the inheritance of the disease (Falchuk, Rogentine, and Strober, 1972; Stokes et al., 1972) . In animals certain HL-A antigens confer a predisposition to malignancy (Lilly, Boyse, and Old, 1964) although whether this is so in man is not clear. It is therefore possible that the relatives of coeliac patients who also have an increased incidence of HL-A8 antigen (Stokes et al., 1973b) also have an increased incidence of malignancy. To explore this possibility, the incidence of malignancy in such relatives has been compared with that occurring in the population as a whole.
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PROPOsmTI, RELATIVES AND METHODS
The propositi were 139 patients, 54 men and 85 women, each with the characteristic flat jejunal mucosa of coeliac disease who were under continued surveillance by the Nutritional and Intestinal Unit. The propositi were selected on the basis of availability and co-operation. They were essentially those attending consecutive clinics and represented approximately one-half of the total clinic. In the 13 families in whom there was more than one coeliac, the patient first diagnosed was the propositus. Two propositi with malignant disease (lymphoma) died during this study.
The age distribution of the 139 propositi at the time of diagnosis of coeliac disease is shown in Table I occurring in these relatives were determined and compared with the number of such deaths expected using cohort mortality rates from tables in Cancer Statistics for England and Wales (Case and Pearson, 1957) ; the method of years at risk was used to calculate expected numbers of such deaths. Since lymphomas and leukaemias were not included in the Case-Pearson tables heading 'All cancers', expected numbers for these causes were calculated from the mortality rates for England and Wales for 1965, applied over the whole range. The period at risk for each individual was taken as his whole life span up to his age at the end of 1972, or at death. This was done because of the virtual impossibility of deciding for each individual a suitable age at which a period at risk should start. (One method of attacking this problem is that of Macklin, 1959.) Cancer deaths at early ages are of course small in number, so that the overall effect will not much increase the expectation, but what effect it does have is also such as to tend to reduce the magnitude of any excess of deaths observed from malignant disease. The Case-Pearson mortality rates are published only back to the quinquennium 1911-15. In the absence of evidence for any trends at the beginning of this century, however, the 1911-15 rates were applied to the years at risk before this. Statistical analysis ofdifferences between numbers of cancer deaths observed and those expected was based upon the Poisson distribution.
RESULTS
The distribution of relatives with regard to their degree of relationship to the propositi and also the numbers alive or dying of cancer or other causes is shown in Table II .
When all cancer deaths are considered there was a significantly increased number of such deaths in relatives of patients with coeliac disease (P <0 -001). In male relatives there was an increased, although not significant, incidence of cancer deaths, but in female relatives the difference between observed and expected deaths was highly significant (P<0 01) ( Table III) .
Comparison of observed and expected numbers of cancer deaths in male and female relatives in the various degrees of relationship to the propositi of each sex is shown in Table IV. This table shows an excess of cancer deaths in fathers of male propositi and in sisters and maternal grandmothers of female propositi. Taking all propositi together, there is also an excess of cancer deaths among I Expected numbers of cancer deaths have been determined separately only for the more commonly occurring primary sites 2 Cancer of colon and rectum are included under large bowel 3 N/D refers to relatives known to have died of cancer but in whom the primary site was not accurately determined
In seeking an explanation for our observed excess of cancer deaths in relatives of coeliac patients, four possibilities need to be considered. 1. The increased incidence of cancer deaths could be due to the fact that the propositi were better able to recall details of relatives dying of cancer than dying of other causes. Indeed, Hagstrom and Ho (1972) showed that recollection for other cancers in the family members may be enhanced if the propositus has cancer in comparison with control propositi who do not. However, only six of the propositi in this study had cancer, and in the remainder particular care was taken not to place undue emphasis upon cancer as a cause of death, not only for this reason, but also to avoid engendering anxiety.
2. The increased incidence of cancer deaths may be related to a family liability to cancer which is independent of the liability to coeliac disease. Indeed, some time ago, Warthin (1913) concluded that 'a marked susceptibility to carcinoma exists in certain families'. Lynch and his colleagues (Lynch and Krush, 1967; Lynch, Krush, and Larsen, 1967) suggested that such 'family cancers' tend to occur at an earlier age in succeeding generations, that multiple sites are a feature, that adenocarcinoma is prominent, and that an autosomal dominant pattern of inheritance may be operative. Lynch, Guirgis, and Albert (1974) have subsequently shown that a familial link for cancer can be demonstrated in female relatives (who develop a breast tumour before the age of 55 years) of propositi in whom there is no evidence of cancer, although Macklin (1959) considered that this familial pattern occurred oinly in relatives of breast cancer propositi. For propositi with tumours other than breast and for a series with no known tumour no familial aggregation could be demonstrated. In the present study it has not been possible to assess the relevance of all these factors but the excess of breast cancer deaths could be the result of the familial nature of the series rather than the effect of a common predisposing factor. 4. The excess of cancer deaths may merely reflect an increase of tumours which are the sequelae of undetected coeliac disease in relatives. If this were the case then the pattern of tumours in relatives might be expected to mirror that of the coeliac patients themselvesthat is, to show an excess of lymphomas and cancer of the oesophagus. The latter has indeed been found to be in excess in relatives (P <0001), but only two deaths from lymphoma were recorded among male relatives and two in female for expectations of 1 80 and 1*22 respectively, and neither difference is statistically significant. The question remains, therefore, whether the observed number of lymphomas is a true reflection of the frequency of their occurrence in relatives. It is possible that such tumours are underreported. Thus coeliac patients, being under close medical supervision, are more likely to come to autopsy than would their relatives with undiagnosed disease. It is also possible that some of the unknown primaries in our series were in fact lymphomas which, in the early years of the survey, might not have been clearly diagnosed or, more likely, that such a diagnosis would have been more difficult for the layman to interpret as a malignant condition. Lastly the estimate of 10% of relatives with undiagnosed disease means that the susceptible subpopulation is well diluted by the rest of the series in which case it may be difficult to establish an excess of lymphomas in this situation.
In summary, our analysis has not detected any general increase in deaths from cancer at all site'. At present it is not possible to say with confidence if the excess of cancer at specific sites is due to a familial effect, either genetic or environmental but independent of coeliac disease, or whether it is the result of a small proportion of relatives with undiagnosed disease displaying an enhanced risk of certain cancers in a pattern similar to that in patients with established coeliac disease.
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